Stefan Oschmann, CEO-elect of Merck Pharmaceutical Company Limited, in this interview with ODIRI UCHENUNU, shares the benefits of the company’s new office in Lagos to Nigerians and the challenges confronting Nigeria’s health care system.
What benefits are to be expected from Merck’s new office in Lagos?
Merck is a leading science and technology company in health care. We recently opened a new office in Lagos, because it is part of our strategy to grow our market share in the West African region.
Nigeria is an evident choice for us. With a population that is known for its entrepreneurial spirit and innovative ideas, this is a perfect match with Merck. Nigeria, Africa’s largest economy, has one of the fastest growing economies in the world and we believe that through our high quality and innovative healthcare and life science specialty products and services we can contribute to that growth.
Besides, a presence through our products, the company has been working closely with the Nigerian government and international organisations to increase access to health solutions in Nigeria.
Together with the Federal Ministry of Health, Merck organised a panel discussion on November 17 that focused on the role the private sector can play in helping countries like Nigeria accelerate progress on Universal Health Coverage (UHC) and the importance of forging partnerships to deliver health solutions for the population. It also took a closer look at the challenges of scaling up and sustaining public-private partnerships and private-private partnerships that seek to improve access to affordable and quality care.
READ MORE
No comments:
Post a Comment